Showing 401-410 of 4174 results for "".
- Review: Botulinum Toxin Shows Potential in Acne Treatmenthttps://practicaldermatology.com/news/systematic-review-highlights-botulinum-toxins-potential-in-acne-treatment/2487204/Botulinum toxin A may offer a potential adjunctive treatment option for both acne vulgaris and acne scarring, according to a recent systematic review published in the Journal of Drugs in Dermatology. Botulinum Toxin S
- Ixekizumab Plus Tirzepatide Improves PASI and Weight Loss in Psoriasis Studyhttps://practicaldermatology.com/news/ixekizumab-plus-tirzepatide-improves-pasi-100-and-weight-loss-in-psoriasis-trial/2487181/New research published online in JAMA Dermatology found that combining ixekizumab with tirzepatide significantly improved both psoriasis clea
- BE BOLD: Bimekizumab Tops Risankizumab for ACR50 Outcomeshttps://practicaldermatology.com/news/be-bold-bimekizumab-tops-risankizumab-for-acr50-outcomes/2487139/New phase 3 data from the BE BOLD trial indicated that bimekizumab (BIMZELX) achieved superior joint efficacy compared with risankizumab (SKYRIZI) in adults with active psoriatic arthritis (PsA), according to a press release from the manufacturer.
- Global Skin Cancer Burden Projected to Rise Through 2050: Studyhttps://practicaldermatology.com/news/global-skin-cancer-burden-projected-to-rise-through-2050/2487086/A new research letter published online in JAMA Dermatology highlights widening global disparities in skin cancer burden and projects continued increases in melanoma, cutaneous squamous cell carcinoma (cSCC), and basal cell c
- Text-Messaging Program Improves Cardiovascular Risk Behaviors in Psoriasishttps://practicaldermatology.com/news/text-messaging-program-improves-cardiovascular-risk-behaviors-in-psoriasis/2487068/Structured text-messaging interventions were associated with an improvement cardiovascular risk-related behaviors and patient activation in adults with psoriasis, according to new study results published online in JAMA Dermatology.
- Meta-Analysis: HS Linked with Elevated Cardiovascular Riskhttps://practicaldermatology.com/news/meta-analysis-hs-linked-with-elevated-cardiovascular-risk/2487046/Patients with hidradenitis suppurativa (HS) may face an increased burden of cardiovascular disease, according to a new systematic review and meta-analysis in the British Journal of Dermatology. Study authors include
- Iron Oxides in Tinted Sunscreens May Improve Hyperpigmentation Protection: Studyhttps://practicaldermatology.com/news/iron-oxides-in-tinted-sunscreens-may-improve-hyperpigmentation-protection-study/2487035/A literature review and product analysis published in the Journal of Drugs in Dermatology highlighted growing evidence supporting the use of iron oxides in tinted sunscreens for managing hyperpigmentation, while also identif
- Long-Term Dupilumab Use Linked to Delayed Relapse in AD: Studyhttps://practicaldermatology.com/news/long-term-dupilumab-use-linked-to-delayed-relapse-in-ad-study/2487027/Patients with moderate-to-severe atopic dermatitis (AD) treated with dupilumab experienced durable symptom control and delayed relapse with long-term therapy, according to a real-world retrospective study published in the Journal
- Report: One-Third of Patients With Vitiligo Receive No Follow-Up Treatmenthttps://practicaldermatology.com/news/report-one-third-of-patients-with-vitiligo-receive-no-follow-up-treatment/2487004/Almost one-third of patients with vitiligo did not receive treatment following diagnosis, according to a report in JAMA Dermatology.
- Reduced AMP Expression Seen in Sensitive Skin Syndrome: Pilot Studyhttps://practicaldermatology.com/news/reduced-amp-expression-seen-in-sensitive-skin-syndrome-pilot-study/2486974/A pilot study published in the Journal of the American Academy of Dermatology evaluated whether key pathophysiologic features of rosacea—Demodex colonization and antimicrobial peptide (AMP) dysregulation—are also present in